Alpha Tau Medical (DRTS) Competitors

Bioventus (NYSE:BVS) and Alpha Tau Medical (NASDAQ:DRTS) are both small-cap medical companies, but which is the superior stock? We will contrast the two businesses based on the strength of their analyst recommendations, earnings, valuation, risk, institutional ownership, profitability, community ranking, media sentiment and dividends.

Do insiders and institutionals hold more shares of BVS or DRTS?

62.9% of Bioventus shares are held by institutional investors. Comparatively, 2.7% of Alpha Tau Medical shares are held by institutional investors. 32.9% of Bioventus shares are held by company insiders. Comparatively, 39.5% of Alpha Tau Medical shares are held by company insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a stock is poised for long-term growth.

Which has more risk & volatility, BVS or DRTS?

Bioventus has a beta of 0.85, indicating that its stock price is 15% less volatile than the S&P 500. Comparatively, Alpha Tau Medical has a beta of 0.83, indicating that its stock price is 17% less volatile than the S&P 500.

Does the MarketBeat Community favor BVS or DRTS?

Bioventus received 11 more outperform votes than Alpha Tau Medical when rated by MarketBeat users. However, 70.37% of users gave Alpha Tau Medical an outperform vote while only 62.50% of users gave Bioventus an outperform vote.

Company	Underperform	Outperform
Bioventus	Outperform Votes 30 62.50%	Underperform Votes 18 37.50%
Alpha Tau Medical	Outperform Votes 19 70.37%	Underperform Votes 8 29.63%

Which has stronger earnings & valuation, BVS or DRTS?

Alpha Tau Medical has lower revenue, but higher earnings than Bioventus. Bioventus is trading at a lower price-to-earnings ratio than Alpha Tau Medical, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Bioventus	$555.06M	1.46	-$156.23M	-$0.61	-16.41
Alpha Tau Medical	N/A	N/A	-$29.16M	-$0.43	-6.23

Do analysts recommend BVS or DRTS?

Bioventus presently has a consensus price target of $15.00, suggesting a potential upside of 49.85%. Alpha Tau Medical has a consensus price target of $8.00, suggesting a potential upside of 198.51%. Given Alpha Tau Medical's stronger consensus rating and higher possible upside, analysts clearly believe Alpha Tau Medical is more favorable than Bioventus.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Bioventus	0 Sell rating(s)	1 Hold rating(s)	2 Buy rating(s)	0 Strong Buy rating(s)	2.67
Alpha Tau Medical	0 Sell rating(s)	0 Hold rating(s)	2 Buy rating(s)	0 Strong Buy rating(s)	3.00

Is BVS or DRTS more profitable?

Alpha Tau Medical has a net margin of 0.00% compared to Bioventus' net margin of -7.11%. Bioventus' return on equity of 15.61% beat Alpha Tau Medical's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Bioventus	-7.11%	15.61%	4.01%
Alpha Tau Medical	N/A	-38.62%	-29.89%

Does the media favor BVS or DRTS?

In the previous week, Bioventus had 5 more articles in the media than Alpha Tau Medical. MarketBeat recorded 6 mentions for Bioventus and 1 mentions for Alpha Tau Medical. Alpha Tau Medical's average media sentiment score of 1.35 beat Bioventus' score of 0.70 indicating that Alpha Tau Medical is being referred to more favorably in the news media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Bioventus	4 Very Positive mention(s)	0 Positive mention(s)	0 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive
Alpha Tau Medical	1 Very Positive mention(s)	0 Positive mention(s)	0 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive

Summary

Alpha Tau Medical beats Bioventus on 9 of the 16 factors compared between the two stocks.